Literature DB >> 31493245

MiR-202-5p/MATN2 are associated with regulatory T-cells differentiation and function in allergic rhinitis.

Li Wang1, Xin Yang2, Wencai Li3, Xicheng Song4, Shasha Kang5.   

Abstract

Regulatory T cells (Tregs) play a crucial role in allergic rhinitis (AR). However, the mechanism of how Tregs are regulated in AR is poorly understood. Here, we aimed to explore the role of Tregs in AR and how Tregs were regulated by miR-202-5P, which was demonstrated to be important in AR. Peripheral blood mononuclear cells (PBMC) were isolated from collected blood samples. Tregs were purified using Regulatory T Cell Isolation Kit, and differentiated from isolated CD4 T cells using recombinant human interleukin-2 (rhIL-2) and transforming growth factor beta (TGF-β). mRNA expression levels of miR-202-5p, matrilin-2 (MATN2), TGF-β1 and interleukin-10 (IL-10) were detected by real-time PCR. The concentrations of IL-4, interleukin-17 (IL-17), IL-10, interferon gamma (IFN-γ) and TGF-β1 were detected by enzyme-linked immunosorbent assay (ELISA). MATN2 protein level was detected by Western blot. MiR-202-5p expression dramatically elevated in PBMCs, CD4+ T cells and Tregs of AR patients. In vitro, miR-202-5p promoted Tregs differentiation via targeting MATN2. MiR-202-5p/MATN2 axis mediated Tregs proliferation and functions. MiR-202-5p/MATN2 are associated with regulatory T-cells differentiation and function in allergic rhinitis.

Entities:  

Keywords:  AR; Differentiation; MATN2; MiR-202-5p; Tregs

Mesh:

Substances:

Year:  2019        PMID: 31493245     DOI: 10.1007/s13577-019-00266-0

Source DB:  PubMed          Journal:  Hum Cell        ISSN: 0914-7470            Impact factor:   4.174


  20 in total

Review 1.  MicroRNAs: genomics, biogenesis, mechanism, and function.

Authors:  David P Bartel
Journal:  Cell       Date:  2004-01-23       Impact factor: 41.582

Review 2.  MicroRNAs: synthesis, mechanism, function, and recent clinical trials.

Authors:  Fazli Wahid; Adeeb Shehzad; Taous Khan; You Young Kim
Journal:  Biochim Biophys Acta       Date:  2010-07-07

Review 3.  Development and maintenance of regulatory T cells.

Authors:  Naganari Ohkura; Yohko Kitagawa; Shimon Sakaguchi
Journal:  Immunity       Date:  2013-03-21       Impact factor: 31.745

4.  Axonally derived matrilin-2 induces proinflammatory responses that exacerbate autoimmune neuroinflammation.

Authors:  Anna Jonas; Stefan Thiem; Tanja Kuhlmann; Raimund Wagener; Attila Aszodi; Cameron Nowell; Karin Hagemeier; Louise Laverick; Victoria Perreau; Vilija Jokubaitis; Ben Emery; Trevor Kilpatrick; Helmut Butzkueven; Melissa Gresle
Journal:  J Clin Invest       Date:  2014-10-20       Impact factor: 14.808

5.  Burden of allergic rhinitis: results from the Pediatric Allergies in America survey.

Authors:  Eli O Meltzer; Michael S Blaiss; M Jennifer Derebery; Todd A Mahr; Bruce R Gordon; Ketan K Sheth; A Larry Simmons; Mark A Wingertzahn; John M Boyle
Journal:  J Allergy Clin Immunol       Date:  2009-07-09       Impact factor: 10.793

Review 6.  How regulatory T cells work.

Authors:  Dario A A Vignali; Lauren W Collison; Creg J Workman
Journal:  Nat Rev Immunol       Date:  2008-07       Impact factor: 53.106

Review 7.  The development of allergic inflammation.

Authors:  Stephen J Galli; Mindy Tsai; Adrian M Piliponsky
Journal:  Nature       Date:  2008-07-24       Impact factor: 49.962

8.  MicroRNA: Biogenesis, Function and Role in Cancer.

Authors:  Leigh-Ann Macfarlane; Paul R Murphy
Journal:  Curr Genomics       Date:  2010-11       Impact factor: 2.236

9.  Resolution of airway inflammation and hyperreactivity after in vivo transfer of CD4+CD25+ regulatory T cells is interleukin 10 dependent.

Authors:  Jennifer Kearley; Jane E Barker; Douglas S Robinson; Clare M Lloyd
Journal:  J Exp Med       Date:  2005-11-28       Impact factor: 14.307

10.  CD4+CD25+ T cells protect against experimentally induced asthma and alter pulmonary dendritic cell phenotype and function.

Authors:  Ian P Lewkowich; Nancy S Herman; Kathleen W Schleifer; Matthew P Dance; Brian L Chen; Krista M Dienger; Alyssa A Sproles; Jaimin S Shah; Jörg Köhl; Yasmine Belkaid; Marsha Wills-Karp
Journal:  J Exp Med       Date:  2005-11-28       Impact factor: 14.307

View more
  6 in total

1.  Circ_0067835 regulates allergic inflammatory response in type-2 innate lymphoid cells in allergic rhinitis (AR) via miR-155/GATA3.

Authors:  Xunshuo Jiang; Taojian Huang; Hongbing Liu; Xubo Chen; Hao Zhang; Ke Liu; Jianjian Deng; Chunping Yang
Journal:  Hum Cell       Date:  2021-04-27       Impact factor: 4.174

Review 2.  The Role of Small Extracellular Vesicles and MicroRNAs in the Diagnosis and Treatment of Allergic Rhinitis and Nasal Polyps.

Authors:  Yiting Liu; Jichao Sha; Cuida Meng; Dongdong Zhu
Journal:  Mediators Inflamm       Date:  2022-06-16       Impact factor: 4.529

3.  A genome-wide association meta-analysis identifies new eosinophilic esophagitis loci.

Authors:  Xiao Chang; Michael March; Frank Mentch; Kenny Nguyen; Joseph Glessner; Huiqi Qu; Yichuan Liu; Glen Furuta; Seema Aceves; Nirmala Gonsalves; Kari Nadeau; Antonella Cianferoni; Jonathan Spergel; Patrick Sleiman; Hakon Hakonarson
Journal:  J Allergy Clin Immunol       Date:  2021-09-25       Impact factor: 14.290

4.  LncRNA HCP5 Participates in the Tregs Functions in Allergic Rhinitis and Drives Airway Mucosal Inflammatory Response in the Nasal Epithelial Cells.

Authors:  Chen Yang; Chengfang Shangguan; Changing Cai; Jing Xu; Xiaohua Qian
Journal:  Inflammation       Date:  2022-02-05       Impact factor: 4.657

Review 5.  The Role of Noncoding RNA in Airway Allergic Diseases through Regulation of T Cell Subsets.

Authors:  Shenghao Cheng; Qingping Tang; Shaobing Xie; Sihui Wen; Hua Zhang; Zhihai Xie; Weihong Jiang
Journal:  Mediators Inflamm       Date:  2022-10-04       Impact factor: 4.529

Review 6.  An update on the roles of immune system-derived microRNAs in cardiovascular diseases.

Authors:  Luke B Roberts; Puja Kapoor; Jane K Howard; Ajay M Shah; Graham M Lord
Journal:  Cardiovasc Res       Date:  2021-11-01       Impact factor: 10.787

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.